Eshelman Ventures
Wilmington, North Carolinaeshelmanventures.com
Overview
Eshelman Ventures is an investment company primarily interested in healthcare companies. The firm was founded by Fred Eshelman, who previously founded and served as CEO and Executive Chairman of Pharmaceutical Product Development (PPDI, NASDAQ) prior to the sale of the company to private equity interests. Although Eshelman Ventures concentrates in healthcare, the firm will consider other themes that are attractive and have large potential markets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Incyclix Bio | Apr 2026 | Series B Extension | Co-investor |
| Pacegenix | Mar 2026 | Early Stage VC | Co-investor |
| Breakthru Medicine | Jan 2026 | Series A | Co-investor |
| Incyclix Bio | Aug 2025 | Series B Extension | Co-investor |
| Paradigm Therapeutics, Inc. | Jun 2025 | VC Round | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
